Healixa Inc. EMOR OTC

Other OTC • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score

24/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Healixa Inc. (EMOR) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 22/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score

24/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

—

未來

N/A

No coverage

✗

过去

0/100

→ Income

✗

健康

0/100

Debt-to-Equity & liquidity

→ Health

护城河

50/100

→ Income

成长

58/100

→ Income

✗

收入

10/100

→ Income

估值概览 — EMOR

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率54.54

EV/EBITDA0.0

每股数据

EPS (TTM)$0.00

每股账面价值$0.00

每股营收$0.00

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2011	$-0.07	$36.68K	$-330.67K	-901.5%
2012	$-0.05	$64.24K	$-419.5K	-653.1%
2017	$0.00	$9.65K	$-49.61K	-514.4%
2018	$-0.01	$6.72K	$-336.73K	-5007.8%
2019	$0.00	$117.93K	$-1.11M	-938.6%
2020	$-0.02	$59.45K	$-15.06M	-25329.4%
2021	$0.00	$0.00	$-2.84M	-
2022	$0.00	$8.82K	$-645.42K	-7316.1%
2023	$-0.01	$598.89K	$-6.73M	-1123.8%
2024	$0.00	$702.91K	$-756.9K	-107.7%